Absorbine Jr Pain Relieving Knee Patch recalled for manufacturing deviations
Unexo Life Sciences is recalling Absorbine Jr Pain Relieving Knee Patch nationwide due to manufacturing process deviations that do not meet FDA standards. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or specified hazard type. The voluntary, precautionary recall was initiated by the manufacturer after discovery of manufacturing process deviations without indication of actual consumer harm.
Plain-English summary
Absorbine Jr Pain Relieving Knee Patch is a topical pain reliever containing 7% camphor and 7% menthol, available in single-patch (UPC 889476412513) and six-patch (UPC 889476413060) packages. Approximately 946,080 patches were distributed nationwide in the United States by Absorbine Jr., LLC, based in Chattanooga, Tennessee.
The manufacturer, Unexo Life Sciences Private Limited, initiated this voluntary recall after identifying deviations in the manufacturing process that do not meet current good manufacturing practice (cGMP) standards required by the FDA. The company's manufacturing facility is located in New Delhi, India.
Consumers who have purchased the recalled patches should stop using them and dispose of them safely. No illnesses or injuries related to this product have been reported. The recall was initiated October 24, 2024, and was terminated September 16, 2025.
The recalled product
- Product
- ABSORBINE JR PAIN RELIEVING KNEE PATCH, Camphor 7%, Menthol 7%, packaged in a) 1 patch (UPC 8 89476 41251 3) and b) 6 patches (UPC 8 89476 41306 0), Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402
- Manufacturer
- Unexo Life Sciences Private Limited
- Category
- Drug — Topical Pain Reliever
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- a) UPC 8 89476 41251 3 b) UPC 8 89476 41306 0
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27